Receptor - Beta-adrenergic

-AR activation) increases cancer cell stiffness, enhancing mobility and promoting metastasis. Studies have shown that blocking ARs can attenuate lung metastasis in various cancer models.

While commonly used for heart conditions, beta-blockers have been found to act as proinflammatory agents in the brain, with research in PMC7686098 indicating that they impair microglia-mediated phagocytosis of synaptic material, increasing neuroinflammation. Chronic Heart Failure (CHF): β1beta sub 1 beta-adrenergic receptor

-ARs are excluded from these areas upon activation, suggesting precise, spatially organized signaling. -AR activation) increases cancer cell stiffness

New studies utilize Rosetta structural modeling to map atomic-scale interactions of β1beta sub 1 β2beta sub 2 beta-adrenergic receptor